Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14231)	7/26/2000 1:41:55 AM
From: aknahow	Read Replies (3) \| Respond to of 17367

Cacaito, first they have to talk and agree and then sign a complicated agreement. A three way agreement at that. No I stick to ten years. Your two years might be the trial itself but then that would not include your friends at the FDA going through the approval process. And then you have forgotten about the mark of Z, no make that the curse of X. Look three days have already passed. AGN does not start trials until next year. When did they first talk to XOMA? But you are too pessimistic on the royalty. If the deal occurs LLY will split 50/50 with BAX and XOMA will get 20%. This is my opinion only and my opinion is just as good as Roberto's which is worthless. <g>